ici 204,219 has been researched along with Thrombosis in 1 studies
zafirlukast: a leukotriene D4 receptor antagonist
Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holbrook, LM | 1 |
| Keeton, SJ | 1 |
| Sasikumar, P | 1 |
| Nock, S | 1 |
| Gelzinis, J | 1 |
| Brunt, E | 1 |
| Ryan, S | 1 |
| Pantos, MM | 1 |
| Verbetsky, CA | 1 |
| Gibbins, JM | 1 |
| Kennedy, DR | 1 |
1 other study available for ici 204,219 and Thrombosis
| Article | Year |
|---|---|
Zafirlukast is a broad-spectrum thiol isomerase inhibitor that inhibits thrombosis without altering bleeding times.
Topics: Animals; Bleeding Time; Blood Platelets; Indoles; Mice; Phenylcarbamates; Sulfhydryl Compounds; Sulf | 2021 |